Amgen IncAMGN:NSQ

140.18
0.53 / 0.38%
611.59k
19.28%
0.5458
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Sep 18 2014 16:41 BST.

Summary

Amgen Inc (AMGN:NSQ) set a new 52-week high during Wednesday's trading session when it reached 141.57. Over this period, the share price is up 19.63%.

52-week range
Today
105.76
Oct 09 2013
141.57
Sep 17 2014
Markit short selling activity
Low
Medium
High
Open140.90
Day high141.00
Day low139.98
Bid140.10
Offer140.23
Previous close140.71
Average volume2.87m
Shares outstanding759.61m
Free float758.78m
P/E (TTM)21.56
Market cap106.88bn USD
EPS (TTM)6.53 USD
Annual div (TTM)2.44 USD
Annual div yield (TTM)1.73%
Div ex-dateAug 12 2014
Div pay-dateSep 05 2014
As of Sep 18 2014 16:41 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Amgen Inc+0.81%+5.15%+10.26%+19.20%+130.39%
S&P 500 INDEX+0.21%+1.51%+6.92%+16.00%+87.36%
USA/HEALTH CARE+0.37%+3.05%+7.59%+19.52%--
USA/BIOTECHNOLOGY-0.53%+1.37%+11.01%+24.78%--
Data delayed at least 15 minutes, as of Sep 18 2014 16:28 BST.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.